Tara Carr, MD
Allergy & Immunology · Tucson, AZNPI 1669634853
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $62,685 of the $76,145 with a category attached, or 82.3%. 19 manufacturers reported payments, led by AstraZeneca at 42.8% of the total. Reporting peaked in 2020 at $34,892 and has fallen 98.3% since, to $601 in 2025. Among allergy & immunology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $532.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$33K
- Novartis$12K
- GSK$9K
- Astrazeneca UK Limited$8K
- Aimmune Therapeutics, Inc.$7K
- Genentech USA, Inc.$3K
- plus $4K from 13 others
Across 140 payments — averaging $1702.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aimmune Therapeutics, Inc.$152K
- Roche Products Limited$54K
- Regeneron$19K
- F. Hoffmann-la Roche AG$6K
- AstraZeneca$4K
- Cumberland Pharmaceuticals, Inc.$3K
What the payments were for
- Consulting fees$62,68582%
- Speaking & faculty fees$7,1889%
- Travel & lodging$2,7824%
- Food & beverage$3,4745%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 57 | $32,566 |
| Novartis | 10 | $12,032 |
| GSK | 4 | $9,116 |
| Astrazeneca UK Limited | 2 | $7,921 |
| Aimmune Therapeutics, Inc. | 1 | $7,188 |
| Genentech USA, Inc. | 2 | $3,262 |
| Regeneron Healthcare Solutions, Inc. | 10 | $2,478 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $351 |
| Amgen(2 entities) | 13 | $287 |
| Sanofi | 6 | $189 |
| Johnson & Johnson | 1 | $144 |
| Pharming Healthcare, Inc. | 2 | $133 |
| Biocryst US Sales Co., LLC | 1 | $125 |
| Bio Products Laboratory USA, Inc. | 6 | $100 |
| Kedrion Biopharma, Inc. | 4 | $90 |
| Grifols USA, LLC | 3 | $73 |
| Stryker | 1 | $59 |
| CSL Behring | 1 | $17 |
| Alk-abello, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$76,145 in reported general payments places this provider in the 90th percentile of 90 allergy & immunology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 78 | $380,675 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 72 | $256,199 |
| Dupixent SyringeDupilumab | 44 | $161,215 |
| Dupixent PenDupilumab | 25 | $95,623 |
| Fasenra PenBenralizumab | 11 | $69,450 |
| Spiriva RespimatTiotropium Bromide | 71 | $42,976 |
| XolairOmalizumab | 11 | $30,325 |
| Breo ElliptaFluticasone/Vilanterol | 38 | $28,176 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 13 | $27,244 |
| Advair HfaFluticasone Propion/Salmeterol | 46 | $21,090 |
| SymbicortBudesonide/Formoterol Fumarate | 47 | $17,605 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $15,895 |
| Qvar RedihalerBeclomethasone Dipropionate | 12 | $9,733 |
| Arnuity ElliptaFluticasone Furoate | 31 | $8,914 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $3,026 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $17 | $380,67578 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $351 | $256,19972 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Arnuity Ellipta | $9,116 | $52,98585 claims |
| Grifols USA, LLCGamunex-C | $73 | $27,24413 claims |
| AstraZenecaSymbicort | $32,566 | $17,60547 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 90 allergy & immunology providers in Arizona.
Other allergy & immunology in Tucson
- Pierre SakaliTucson$25K
- George MakolTucson$13K
- Nicole LahoodTucson$13K
- Nabeeh LahoodTucson$13K
- Martin BartelsTucson$7K
- Puneet ShroffTucson$4K
- Kudagal MurthyTucson$3K
- Anjali JainTucson$2K
- Kaitlyn LeaheyTucson$1K
- Michael ManningScottsdale$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.